New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur
Oncology March 06,2024
Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur
Oncology March 06,2024
Cancer drug restores immune system's ability to fight tumors

Cancer drug restores immune system's ability to fight tumors

by University of Texas at AustinCredit: Pixabay/CC0 Public DomainA new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The Universit
Oncology March 06,2024
Cancer drug restores immune system's ability to fight tumors

Cancer drug restores immune system's ability to fight tumors

by University of Texas at AustinCredit: Pixabay/CC0 Public DomainA new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The Universit
Oncology March 06,2024
New insights into sarcoma open novel avenues of study

New insights into sarcoma open novel avenues of study

by Karolinska InstitutetCredit: CC0 Public DomainUndifferentiated uterine sarcoma is a very rare but extremely aggressive cancer type. It can be divided into four groups with different characteri
Oncology March 06,2024
New insights into sarcoma open novel avenues of study

New insights into sarcoma open novel avenues of study

by Karolinska InstitutetCredit: CC0 Public DomainUndifferentiated uterine sarcoma is a very rare but extremely aggressive cancer type. It can be divided into four groups with different characteri
Oncology March 06,2024
Fake organs guide the way for 'impossible' cancer surgery

Fake organs guide the way for 'impossible' cancer surgery

by Mark Michaud,University of Rochester Medical CenterAhmed Ghazi, M.D., holds a lifelike model of Anthony Camnetar's kidney. Credit: University of Rochester Medical CenterAnthony Camnetar r
Oncology March 06,2024
Fake organs guide the way for 'impossible' cancer surgery

Fake organs guide the way for 'impossible' cancer surgery

by Mark Michaud,University of Rochester Medical CenterAhmed Ghazi, M.D., holds a lifelike model of Anthony Camnetar's kidney. Credit: University of Rochester Medical CenterAnthony Camnetar r
Oncology March 06,2024
Shorter drug treatment OK for many breast cancer patients

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo
Oncology March 06,2024
Shorter drug treatment OK for many breast cancer patients

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo
Oncology March 06,2024
Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de
Oncology March 06,2024
Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de
Oncology March 06,2024
Novel silver compounds offer a potential cancer treatment breakthrough

Novel silver compounds offer a potential cancer treatment breakthrough

by Marianne J. Cronjé And Reinout Meijboom,The ConversationOesophageal cancer cells before the silver-based compounds have been added.The development of chemotherapeutic drugs to treat various c
Oncology March 06,2024
Novel silver compounds offer a potential cancer treatment breakthrough

Novel silver compounds offer a potential cancer treatment breakthrough

by Marianne J. Cronjé And Reinout Meijboom,The ConversationOesophageal cancer cells before the silver-based compounds have been added.The development of chemotherapeutic drugs to treat various c
Oncology March 06,2024
Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys
Oncology March 06,2024
Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys
Oncology March 06,2024
Study: 'GPS' seed devices effective in localizing breast tumors

Study: 'GPS' seed devices effective in localizing breast tumors

by Tim Tedeschi,University of CincinnatiCredit: Pixabay/CC0 Public DomainUniversity of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remo
Oncology March 06,2024
Study: 'GPS' seed devices effective in localizing breast tumors

Study: 'GPS' seed devices effective in localizing breast tumors

by Tim Tedeschi,University of CincinnatiCredit: Pixabay/CC0 Public DomainUniversity of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remo
Oncology March 06,2024
Advanced ovarian cancer drug gets initial 'no' for NHS in England

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r
Oncology March 06,2024
Advanced ovarian cancer drug gets initial 'no' for NHS in England

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r
Oncology March 06,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com